Enable your JavaScript to use Numstock


Numstock » ACOR

ACOR Stock Analysis

The latest metrics for Acorda Therapeutics, Inc

Value

Metric Target Value
Price / Earnings Ratio < 12.0 -1.08
Price / Book Value Ratio < 1.5 0.3
Price / Sales Ratio < 2.0 0.41
PEG Ratio < 1.0 0.51
EV / EBITDA Ratio < 8.0 -2.34
Price / FCF Ratio Last Year < 15.0 1.38
Price / FCF Ratio Last Quarter < 15.0 -1.67
Price / TBV Ratio Last Year < 0.7 -0.86
Price / TBV Ratio Last Quarter < 0.7 -0.67
Price / NCAV Ratio Last Year < 0.7 -0.53
Price / NCAV Ratio Last Quarter < 0.7 -0.3

Efficiency

Metric Target Value
ROE Last Year > 25.0% 5.95
ROE Last Quarter > 25.0% -63.8
ROA Last Year > 15.0% 2.59
ROA Last Quarter > 15.0% -29.95
ROTA Last Year > 20.0% 10.77
ROTA Last Quarter > 20.0% -3.72
ROIC Last Year > 20.0% 11.32
ROIC Last Quarter > 20.0% -6.82
ROCE Last Year > 20.0% 8.18
ROCE Last Quarter > 20.0% -4.43
Inventory Turnover Last Year > 4.0 3.42
Inventory Turnover Last Quarter > 4.0 0.29
Pre-tax Margin Last Year > 20.0% 9.04
Pre-tax Margin Last Quarter > 20.0% -699
Accounts Payable Turnover Last Year > 3.0 2.03
Accounts Payable Turnover Last Quarter > 3.0 0.11
Accounts Receivable Turnover Last Year > 5.0 4.24
Accounts Receivable Turnover Last Quarter > 5.0 0.34

Health

Metric Target Value
Current Ratio Last Year > 1.5 3.77
Current Ratio Last Quarter > 1.5 2.24
Quick Ratio Last Year > 1.5 3.56
Quick Ratio Last Quarter > 1.5 2.05
Flow Ratio Last Year < 1.25 1.68
Flow Ratio Last Quarter < 1.25 0.44
Debt / Equity Ratio Last Year < 0.5 0.56
Debt / Equity Ratio Last Quarter < 0.5 1.25
Debt / EBITDA Ratio Last Year < 4.0 -20.97
Debt / EBITDA Ratio Last Quarter < 4.0 -21.44
Debt / NCAV Ratio Last Year < 2.0 -2.15
Debt / NCAV Ratio Last Quarter < 2.0 -1.23
Long-term Debt / Working Capital Ratio Last Year < 2.0 0.88
Long-term Debt / Working Capital Ratio Last Quarter < 2.0 2.02
Interest Coverage Ratio Ratio Last Year > 8.0 4.39
Interest Coverage Ratio Last Quarter > 8.0 7.27
FCF / Sales Ratio Last Year > 8.0% 24.92
FCF / Sales Ratio Last Quarter > 8.0% -91.14

Growth

Metric Target Value
Earnings Yield > 12% -92.74
Ebit Yield Last Year > 12% 19.71
Ebit Yield Last Quarter > 12% -7.57
FCF Yield Last Year > 10% 135.5
FCF Yield Last Quarter > 10% -50.17
Forward P/E to Trailing P/E Ratio > 1.1 0.0
Operating Cash Flow / EPS Ratio Last Year > 1.2 -1.92
Operating Cash Flow / EPS Ratio Last Quarter > 1.2 0.3

Dividends

Metric Target Value
Dividend Yield > 2.0% 0.0
FCF / Dividends Paid Ratio Last Year > 2.5 0.0
FCF / Dividends Paid Ratio Last Quarter > 2.5 0.0
EPS / Dividends Paid Last Year > 2.5 0.0
EPS / Dividends Paid Last Quarter > 2.5 0.0
Payout Ratio < 40.0% 0.0

Ratings

Metric Target Value
Altman Z-score Last Year ≥ 3.5 0.58
Altman Z-score Last Quarter ≥ 3.5 -0.94